AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing
Recently, NCCL announced the results of ‘2019-nCoV nucleic acid detection capability verification’. Shanghai Yunsheng Medical Laboratory (fully owned subsidiary of AccuraGen Holdings) passed the quality evaluation with ‘fluorescent real-time PCR’. The test results are completely consistent with the standards.
A total of 12 quality assessment samples were issued this time, and a total of 844 laboratories submitted valid test results; of which 701 passed (83.1%) and 143 failed (16.9%).